Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955708 · ClinicalTrials.gov registry record
Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
A clinical trial, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- 1,308
- Enrollment target
NCT00955708: Clinical Trial study, sponsored by Boston Scientific Corporation.
NCT00955708 is a clinical trial that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 1,308 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00955708 was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- 1,308 participants
- Enrollment target
Study Summary
The primary purpose of the LSR of ACUITY Spiral is to evaluate and report on the long-term performance of the ACUITY Spiral Left Ventricular Lead.
Interventions
- DEVICE ACUITY Spiral Left Ventricular Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,308 participants |
| Start Date | 2009-08-04 |
| Est. Completion | 2018-02-28 |
Why NCT00955708 stopped before completion
NCT00955708 is an observational study that tracks outcomes without assigning an intervention. Its 1,308 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which ACUITY Spiral Left Ventricular Lead is the first listed.
NCT00955708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00955708 about?
NCT00955708 is a clinical study titled "Longitudinal Surveillance Registry (LSR) of ACUITY Spiral". The primary purpose of the LSR of ACUITY Spiral is to evaluate and report on the long-term performance of the ACUITY Spiral Left Ventricular Lead.
What is the current status of trial NCT00955708?
This trial is currently terminated. The enrollment target is 1,308 participants. The study started on 2009-08-04. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT00955708?
The interventions under investigation include: ACUITY Spiral Left Ventricular Lead (DEVICE).
Who is sponsoring clinical trial NCT00955708?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06136624 · 1,310 participants · Phase 3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- NCT06517901 · 1,306 participants · NA
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
- NCT04171323 · 1,305 participants · NA
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
- NCT06556433 · 1,312 participants · NA
Family-Based Financial Incentives Intervention for Smoking Cessation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI